RNAC

RNAC R&D Expenses

$68.39MTTM · USD

Period ending:

RNAC FY R&D ExpensesUSD
RNAC FY R&D Expenses2014-12-31: $10.49M2015-12-31: $22.98M2016-12-31: $29.70M2017-12-31: $45.17M2018-12-31: $47.69M2019-12-31: $42.74M2020-12-31: $54.51M2021-12-31: $68.74M2022-12-31: $72.38M2023-12-31: $71.26M2024-12-31: $45.11M2025-12-31: $58.03M$72.38M$0.00
2014-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

RNAC r&d expenses history

Research and development spending. The available annual fiscal periods series contains 12 observations from Dec 31, 2014 to Dec 31, 2025.

Cartesian Therapeutics Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
58,034,000
45,105,000
71,260,000
72,377,000
68,736,000
54,505,000
42,743,000
47,687,000
45,165,000
29,702,000
22,980,000
10,486,000

Compare r&d expenses

All RNAC financial metrics · RNAC stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.